期刊文献+

阿尔茨海默病及血管性痴呆患者血清胆固醇、IL-6和V itB_(12)等水平的临床观测 被引量:6

Observation of Serum Cholesterol, IL-6 and VitB_(12) Levels in Alzheimer's Disease or Vascular Dementia Patients
下载PDF
导出
摘要 目的:观测阿尔茨海默病(AD)及血管性痴呆(VD)患者血清胆固醇、白细胞介素6(IL-6)和维生素B12(V itB12)等水平的异同。方法:利用酶法进行血脂分析;采用双抗体夹心酶联免疫法(ELISA)测定血清白细胞介素6(IL-6)、白细胞介素10(IL-10)和肿瘤坏死因子α(TNFα)含量;电化学发光法检测V itB12及叶酸水平。结果:AD和VD组血清总胆固醇(T-Ch)、低密度脂蛋白胆固醇(LDL-C)及甘油三酯(TG)水平均显著高于正常对照组;AD组IL-6及TNFα明显高于VD组和正常对照组;VD组叶酸水平明显降低。结论:血脂升高可能同为AD及VD的病理生理基础,AD同时伴有明显炎症反应,叶酸水平降低为VD的另一病理特征。 Objective: To find the difference between Alzheimer's disease and vascular dementia patients in levels of serum cholesterol, interleukine-6 ( IL-6 ) and vitamin B12 (Vit B12 ). Methods: Serum cholesterol was detected with enzyme assay, interleukines was detected with ELISA, Vit B12 and the folic acid was detected with electrochemical luminescence (ECL) assay. Results: The levels of serum T-Ch, LDL-C and TG in AD or VD patients were significantly higher than the levels in normal people. AD patients' IL-6 and TNFα were higher than VD patients or normal people. The folic acid levels in VD patients was low. Conclusion: AD or VD patients have a high level of serum cholesterol may be their common phys- iologic basis. Besides, AD patient had inflammatory reaction and VD patient had a low level of folic acid.
出处 《江苏大学学报(医学版)》 CAS 2006年第1期48-49,52,共3页 Journal of Jiangsu University:Medicine Edition
基金 江苏省社会发展基金资助项目(BS-2003051)
关键词 阿尔茨海默病 胆固醇 白细胞介素6 叶酸 Alzheimer's disease Cholesterol Interleukine-6 Folic acid
  • 相关文献

参考文献7

二级参考文献35

  • 1Town T, Vendrame M, Patel A ,et al. Reduced Th1 and enhanced Th2immunity after immunization with Alzheimer' s beta-amyloid ( 1-42 )[ J ]. J Neuroimmunol,2002,132 ( 1-2 ) :49-59.
  • 2Haugabook S J,Le T,Yager D,et al. Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin [J]. FASEB J,2001,15( 1 ) :16-18.
  • 3Beloosesky Y, Salman H, Bergman M, et al. Cytokine levels and phagocytic activity in patients with Alzheimer' s disease [ J ].Gerontology ,2002,48 ( 3 ): 128-132.
  • 4Szczepanik A M, Funes S, Petko W, et al. IL-4, IL-10 and IL-13modulate A beta ( 1-42 ) -induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line [ J ]. J Neuroimmunol,2001,113 ( 1 ) :49-62.
  • 5[1]Shi J, Perry G, Smith MA, et al. Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiology of Aging, 2000, 21 (2) :375.
  • 6[2]Kudo T, Imaizumi K, Tanimukai H, et al. Are cerebrovascular factor involved in Alzheimer's disease? Neurobiology of aging, 2000,21 (2): 215.
  • 7[3]M.M.B Breteler. Vascular risk factors for Alzheimers disease: An epidemiology perspective. Neurobiology of Aging, 2000,21 (2): 153.
  • 8[4]Launer L J, White LR, Petrovitch H, et al. Cholesterol and neuropathologic markers of AD. Neurology, 2001,57(8): 1147.
  • 9[5]Shalden MF, Larson EB, Yukawa M. The epidemiology of Alzheimer's disease and vascular dementia in Japanese and Africian-Americian populations: the search for etiological clues. Neurobiology of Aging, 2000,21(2):171.
  • 10[6]Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiology of Aging, 2000,21(2) :321.

共引文献23

同被引文献62

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部